Back to Search Start Over

ASPI: a public–private partnership to develop treatments for autism

ASPI: a public–private partnership to develop treatments for autism

Authors :
Declan G. Murphy
Kyle Wathen
Abigail Bangerter
Husseini K. Manji
Gahan Pandina
Geraldine Dawson
Robert L. Hendren
Nikolay V. Manyakov
Bennett L. Leventhal
Shyla Jagannatha
Wayne C. Drevets
Seth Ness
Source :
Nature Reviews Drug Discovery. 19:219-220
Publication Year :
2020
Publisher :
Springer Science and Business Media LLC, 2020.

Abstract

Numerous potential therapeutic targets are being investigated in autism spectrum disorder (ASD). Here, we discuss a platform trial approach for designing proof-of-concept (POC) clinical studies of ASD — via the Autism Spectrum POC Initiative (ASPI) — that can be conducted through a public–private partnership with the aim of finding effective treatments in the most expeditious manner. Numerous potential therapeutic targets are being investigated in autism spectrum disorder (ASD). Here, we discuss a platform trial approach for designing proof-of-concept (POC) clinical studies of ASD — via the Autism Spectrum POC Initiative (ASPI) — that can be conducted through a public–private partnership with the aim of finding effective treatments in the most expeditious manner.

Details

ISSN :
14741784 and 14741776
Volume :
19
Database :
OpenAIRE
Journal :
Nature Reviews Drug Discovery
Accession number :
edsair.doi...........c8d39e15c726a948d9d8de9678498a85
Full Text :
https://doi.org/10.1038/d41573-020-00012-4